Literature DB >> 32209018

Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition.

Mark B Horton1, Christopher J Brady2, Jerry Cavallerano3,4, Michael Abramoff5,6,7,8,9,10, Gail Barker11, Michael F Chiang12,13, Charlene H Crockett14, Seema Garg15, Peter Karth16, Yao Liu17, Clark D Newman18, Siddarth Rathi19, Veeral Sheth20, Paolo Silva3,4, Kristen Stebbins21, Ingrid Zimmer-Galler22.   

Abstract

Contributors The following document and appendices represent the third edition of the Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy. These guidelines were developed by the Diabetic Retinopathy Telehealth Practice Guidelines Working Group. This working group consisted of a large number of subject matter experts in clinical applications for telehealth in ophthalmology. The editorial committee consisted of Mark B. Horton, OD, MD, who served as working group chair and Christopher J. Brady, MD, MHS, and Jerry Cavallerano, OD, PhD, who served as cochairs. The writing committees were separated into seven different categories. They are as follows: 1.Clinical/operational: Jerry Cavallerano, OD, PhD (Chair), Gail Barker, PhD, MBA, Christopher J. Brady, MD, MHS, Yao Liu, MD, MS, Siddarth Rathi, MD, MBA, Veeral Sheth, MD, MBA, Paolo Silva, MD, and Ingrid Zimmer-Galler, MD. 2.Equipment: Veeral Sheth, MD (Chair), Mark B. Horton, OD, MD, Siddarth Rathi, MD, MBA, Paolo Silva, MD, and Kristen Stebbins, MSPH. 3.Quality assurance: Mark B. Horton, OD, MD (Chair), Seema Garg, MD, PhD, Yao Liu, MD, MS, and Ingrid Zimmer-Galler, MD. 4.Glaucoma: Yao Liu, MD, MS (Chair) and Siddarth Rathi, MD, MBA. 5.Retinopathy of prematurity: Christopher J. Brady, MD, MHS (Chair) and Ingrid Zimmer-Galler, MD. 6.Age-related macular degeneration: Christopher J. Brady, MD, MHS (Chair) and Ingrid Zimmer-Galler, MD. 7.Autonomous and computer assisted detection, classification and diagnosis of diabetic retinopathy: Michael Abramoff, MD, PhD (Chair), Michael F. Chiang, MD, and Paolo Silva, MD.

Entities:  

Keywords:  artificial intelligence; diabetic retinopathy; telehealth; telemedicine; teleophthalmology

Mesh:

Year:  2020        PMID: 32209018      PMCID: PMC7187969          DOI: 10.1089/tmj.2020.0006

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  229 in total

1.  High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema.

Authors:  Christopher J Rudnisky; Brad J Hinz; Matthew T S Tennant; Alexander R de Leon; Mark D J Greve
Journal:  Ophthalmology       Date:  2002-02       Impact factor: 12.079

2.  Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis.

Authors:  J Peter Campbell; Esra Ataer-Cansizoglu; Veronica Bolon-Canedo; Alican Bozkurt; Deniz Erdogmus; Jayashree Kalpathy-Cramer; Samir N Patel; James D Reynolds; Jason Horowitz; Kelly Hutcheson; Michael Shapiro; Michael X Repka; Phillip Ferrone; Kimberly Drenser; Maria Ana Martinez-Castellanos; Susan Ostmo; Karyn Jonas; R V Paul Chan; Michael F Chiang
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

3.  Telemedicine model to prevent blindness from familial glaucoma.

Authors:  Sandra E Staffieri; Jonathan B Ruddle; Lisa S Kearns; Julie M Barbour; Thomas L Edwards; Padma Paul; David A Mackey
Journal:  Clin Exp Ophthalmol       Date:  2011-04-27       Impact factor: 4.207

4.  Validated System for Centralized Grading of Retinopathy of Prematurity: Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.

Authors:  Ebenezer Daniel; Graham E Quinn; P Lloyd Hildebrand; Anna Ells; G Baker Hubbard; Antonio Capone; E Revell Martin; Candace P Ostroff; Eli Smith; Maxwell Pistilli; Gui-Shuang Ying
Journal:  JAMA Ophthalmol       Date:  2015-06       Impact factor: 7.389

5.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

6.  Central corneal thickness measurement with the Pentacam Scheimpflug system, optical low-coherence reflectometry pachymeter, and ultrasound pachymetry.

Authors:  Yaniv Barkana; Yariv Gerber; Uri Elbaz; Shulamit Schwartz; Gie Ken-Dror; Isaac Avni; David Zadok
Journal:  J Cataract Refract Surg       Date:  2005-09       Impact factor: 3.351

7.  Assessment of a Tele-education System to Enhance Retinopathy of Prematurity Training by International Ophthalmologists-in-Training in Mexico.

Authors:  Samir N Patel; Maria Ana Martinez-Castellanos; David Berrones-Medina; Ryan Swan; Michael C Ryan; Karyn E Jonas; Susan Ostmo; J Peter Campbell; Michael F Chiang; R V Paul Chan
Journal:  Ophthalmology       Date:  2017-04-03       Impact factor: 12.079

8.  Clinical evaluation of patients with diabetic retinopathy: accuracy of the Inoveon diabetic retinopathy-3DT system.

Authors:  Stephen R Fransen; Thomas C Leonard-Martin; William J Feuer; P Lloyd Hildebrand
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

9.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

10.  Older-onset diabetes and lens opacities. The Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; Q Wang; S E Moss
Journal:  Ophthalmic Epidemiol       Date:  1995-03       Impact factor: 1.648

View more
  15 in total

1.  Telehealth Screening for Diabetic Retinopathy: Economic Modeling Reveals Cost Savings.

Authors:  Delaney M Curran; Brian Y Kim; Natasha Withers; Donald S Shepard; Christopher J Brady
Journal:  Telemed J E Health       Date:  2022-01-24       Impact factor: 5.033

2.  Telemedicine Use by Oculoplastic Surgeons During the COVID-19 Pandemic.

Authors:  Gary J Lelli; Susan Luo; Yao Liu; Suzanne W van Landingham
Journal:  Telemed J E Health       Date:  2021-09-29       Impact factor: 5.033

3.  Hybrid Telehealth Medical Retina Clinic Due to Provider Exposure and Quarantine During COVID-19 Pandemic.

Authors:  Itay Chowers; Jaime Levy; Hamzah Aweidah; Khaled Safadi; Alan Jotkowitz
Journal:  Clin Ophthalmol       Date:  2020-10-21

4.  Using Public Datasets to Identify Priority Areas for Ocular Telehealth.

Authors:  Christopher J Brady; Samantha D'Amico; Natasha Withers; Brian Y Kim
Journal:  Telemed J E Health       Date:  2021-02-18       Impact factor: 3.536

5.  Open-care telemedicine in ophthalmology during the COVID-19 pandemic: a pilot study.

Authors:  A Arntz; D Khaliliyeh; A Cruzat; X Rao; G Rocha; A Grau; P Altschwager; V Azócar
Journal:  Arch Soc Esp Oftalmol (Engl Ed)       Date:  2020-10-13

6.  Artificial Intelligence Segmented Dynamic Video Images for Continuity Analysis in the Detection of Severe Cardiovascular Disease.

Authors:  Xi Zhu; Wei Xia; Zhuqing Bao; Yaohui Zhong; Yu Fang; Fei Yang; Xiaohua Gu; Jing Ye; Wennuo Huang
Journal:  Front Neurosci       Date:  2021-02-10       Impact factor: 4.677

7.  The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management.

Authors:  Stephanie J Fonda; Sven-Erik Bursell; Drew G Lewis; Dawn Clary; Dara Shahon; Mark B Horton
Journal:  Telemed J E Health       Date:  2020-01-31       Impact factor: 3.536

Review 8.  Telemedicine for Retinopathy of Prematurity.

Authors:  Christopher J Brady; Samantha D'Amico; J Peter Campbell
Journal:  Telemed J E Health       Date:  2020-03-25       Impact factor: 3.536

Review 9.  The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.

Authors:  Janusz Pieczynski; Patrycja Kuklo; Andrzej Grzybowski
Journal:  Ophthalmol Ther       Date:  2021-06-22

Review 10.  Telemedicine in ophthalmology in view of the emerging COVID-19 outbreak.

Authors:  Adir C Sommer; Eytan Z Blumenthal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.